Clinical Trial Update: Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 pharmacogenetic study of bisoprolol in Egyptian patients with acute coronary syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Bisoprolol (Bisoprolol)

Snippet

Sponsor: Damanhour University | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED